SCHEMBL2116108

SCHEMBL2116108

Clc1nc(Cc2ccccc2)nc(Cl)c1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
MAPT P10636 1/20 0.49
DHPS P49366 1/20 0.48
CALM1 P0DP23 1/20 0.46
ALDH1A1 P00352 3/20 0.45
NPC1 O15118 2/20 0.45
HTT P42858 1/20 0.45
RAB9A P51151 1/20 0.45
CYP1A2 P05177 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
CYP2D6 P10635 1/20 0.43
LMNA P02545 1/20 0.43
MAPK1 P28482 2/20 0.41
TSHR P16473 1/20 0.41
PDE4A P27815 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2614741 0.81 CALM1 (0.61) L3MBTL1MEN1KMT2ACALM1ALDH1A1
SCHEMBL2118469 0.81 CYP3A4 (0.41) L3MBTL1MEN1KMT2AMAPTALDH1A1
SCHEMBL1390574 0.80 CALM1 (0.48) L3MBTL1MEN1KMT2AMAPTDHPS
SCHEMBL783742 0.79 DHPS (0.56) L3MBTL1MEN1KMT2AMAPTDHPS
SCHEMBL631807 0.78 ALDH1A1 (0.47) L3MBTL1MEN1KMT2AMAPTDHPS
SCHEMBL2115442 0.77 CETP (0.42) L3MBTL1KMT2AMAPTCYP1A2CYP3A4
SCHEMBL6640753 0.76 DHPS (0.53) L3MBTL1MEN1KMT2AMAPTDHPS
SCHEMBL30910330 0.74 L3MBTL1 (0.44) L3MBTL1MEN1KMT2AMAPTDHPS
SCHEMBL9322005 0.74 ALDH1A1 (0.52) L3MBTL1MEN1KMT2AMAPTCALM1
SCHEMBL11341349 0.74 HTR2C (0.43) L3MBTL1MEN1KMT2AMAPTDHPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101646657-B Process for producing trichloropyrimidine compound SUMITOMO CHEMICAL CO JP 2012-08-08 CN disclosed
US-8158787-B2 Process for producing trichloropyrimidine compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-04-17 US disclosed
US-20100160630-A1 PROCESS FOR PRODUCING TRICHLOROPYRIMIDINE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-24 US disclosed
EP-2128141-A1 PROCESS FOR PRODUCING TRICHLOROPYRIMIDINE COMPOUND Sumitomo Chemical Company, Limited (JP) 2009-12-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160630-A1 PROCESS FOR PRODUCING TRICHLOROPYRIMIDINE COMPOUND DPYD, TYMP, TST L3MBTL1 3434/4885MEN1 4481/4885KMT2A 3104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.